J&J Named Inaugural Global Impact Winner by the Healthcare Businesswomen’s Association

On Feb 6, 2026

Johnson & Johnson has been named the inaugural recipient of the Global Impact Award by the Healthcare Businesswomen’s Association (HBA), a global leadership accelerator, business growth partner, and enterprise solution for the healthcare and life sciences industries.

The HBA’s first-ever Global Impact Award recognizes organizations whose leadership practices, innovation strategies, collaboration models, and business performance work together to drive meaningful, sustained change across healthcare and life sciences. The award takes an enterprise-wide view, celebrating how companies develop leaders, advance innovation, build partnerships, and align purpose with performance to deliver impact at scale for patients, the workforce, and healthcare systems worldwide.

“Healthcare is inherently global, and leadership must be as well,” said Mary Stutts, chief executive officer of the HBA. “This inaugural award recognizes organizations that embed purpose into how they lead, innovate, and operate at scale. Johnson & Johnson demonstrates what it looks like to translate values into measurable impact across markets, communities, and healthcare systems worldwide.”

Johnson & Johnson will be celebrated during the HBA’s Global Ascension Leadership Experience on 23-24 April 2026, in San Diego, California. Designed for leaders navigating an increasingly complex healthcare landscape, this two-day leadership experience convenes influential voices across biotech, biopharma, medtech, digital health, research, healthcare, and the broader life sciences ecosystem for future-focused learning, intentional connection, and leadership insight. Registration for the Global Ascension Leadership Experience is now open.

Johnson & Johnson was named the inaugural recipient of the HBA Global Impact Award for translating values-driven leadership into measurable impact for patients, the healthcare workforce, and health systems around the world.

Guided by the company’s Credo values, Johnson & Johnson embeds purpose across leadership and talent development, innovation, and social impact—aligning decisions globally around long-term commitments to patients, employees, communities, and shareholders.

“We are deeply honored to receive the HBA Global Impact Award, which reflects the dedication and passion of our Johnson & Johnson teams worldwide,” said Vanessa Broadhurst, executive vice president, global corporate affairs, Johnson & Johnson. “This recognition affirms our ongoing commitment to developing leaders, nurturing innovation, and advancing partnerships that drive meaningful change for patients, our workforce, and healthcare systems everywhere.”

To access more business news, visit NJB News Now.

Related Articles: